Viewing StudyNCT02391727



Ignite Creation Date: 2024-05-06 @ 3:52 AM
Last Modification Date: 2024-10-26 @ 11:40 AM
Study NCT ID: NCT02391727
Status: COMPLETED
Last Update Posted: 2018-11-16
First Post: 2015-03-09

Brief Title: Safety Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors
Sponsor: Synermore Biologics Co Ltd
Organization: Synermore Biologics Co Ltd

Conditions & Keywords Data

Conditions:
Name
Colon Cancer Breast Cancer Cancer of the Head and Neck
Keywords:
Name View
cetuximab View
SYN004 View